Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting

被引：0
|
作者：
Kwon, J. H. [1 ]
Kang, J-H. [2 ]
Lee, Y-G. [3 ]
Park, K. U. [4 ]
An, H. J. [5 ]
Sohn, J. [6 ]
Seol, Y. M. [7 ]
Lee, H. [8 ]
Yun, H-J. [9 ,10 ]
Ahn, J. S. [11 ]
Kim, H. J. [12 ]
机构：
[1] Hallym Univ, Kangdong Sacred Heart Hosp, Div Hematooncol, Dept Internal Med,Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Seoul ST Marys Hosp, Oncol, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Internal Med, Sch Med, Seoul, South Korea
[4] Keimyung Univ, Sch Med, Internal Med, Dongsan Med Ctr, Daegu, South Korea
[5] Catholic Univ Korea, St Vincents Hosp, Dept Med Oncol, Coll Med, Suwon, South Korea
[6] Yonsei Univ, Div Med Oncol, Dept Internal Med, Coll Med, Seoul, South Korea
[7] Pusan Natl Univ, Sch Med, Internal Med, Pusan Natl Univ Hosp, Busan, South Korea
[8] Ajou Univ, Sch Med, Hematol Oncol, Ajou Univ Hosp, Suwon, South Korea
[9] Chungnam Natl Univ, Sch Med, Daejeon, South Korea
[10] Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea
[11] Samsung Med Ctr, Hematol & Oncol, Seoul, South Korea
[12] ASAN Med Ctr, Clin Epidemiol & Biostat, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1705P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
    Kang, Jin Hyoung
    Kwon, Jung Hye
    Lee, Yun-Gyoo
    Park, Keon Uk
    An, Ho Jung
    Sohn, Joohyuk
    Seol, Young Mi
    Lee, Hyunwoo
    Yun, Hwan-Jung
    Ahn, Jin Seok
    Yang, Ji Hyun
    Song, Hunho
    Koo, Dong-Hoe
    Kim, Jin Young
    Kim, Gun Min
    Kim, Hwa Jung
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 907 - 916
  • [2] Palonosetron plus aprepitant and dexamethasone is a highly effective combination to prevent chemotherapy-induced nausea & vomiting after emetogenic chemotherapy
    Grote, T.
    Hajdenberg, J.
    Cartmell, A.
    Ferguson, S.
    Gallagher, S.
    Piraccini, G.
    Charu, V.
    EJC SUPPLEMENTS, 2005, 3 (02): : 371 - 372
  • [3] EFFICACY OF TRIPLET ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: PALONOSETRON, APREPITANT, AND DEXAMETHASONE
    Hayashi, M.
    Miura, S.
    Sato, K.
    Makino, M.
    Kobayashi, O.
    Miyao, H.
    Iwashima, A.
    Ichikawa, K.
    Koshio, J.
    Watanabe, S.
    Tanaka, J.
    Kagamu, H.
    Yokoyama, A.
    Narita, I.
    Yoshizawa, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 88 - 88
  • [4] Palonosetron versus Granisetron in Combination with Aprepitant and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy: A Single-Institutional Retrospective Cohort Study
    Miyoshi, Takanori
    Miyashita, Hiroo
    Matsuo, Naomi
    Odawara, Miki
    Hori, Minako
    Hiraki, Yoichi
    Kawanaka, Hirofumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (10) : 1413 - 1418
  • [5] Analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting with moderately and highly emetogenic chemotherapy
    Molassiotis, Alex
    Nguyen, Allison Martin
    Rittenberg, Cynthia N.
    Makalinao, Alex
    Carides, Alexandra
    FUTURE ONCOLOGY, 2013, 9 (10) : 1443 - 1450
  • [6] Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21
    Kim, Hyo Jung
    Shin, Sang Won
    Song, Eun-Kee
    Lee, Na-Ri
    Kim, Jun Suk
    Ahn, Jin Seok
    Yun, Hwan-Jung
    Cho, Yo-Han
    Park, Keon Uk
    Kim, Si-Young
    Jang, Joung Soon
    Kim, Sang-We
    Lee, Hyun Woo
    Lee, Se Ryeon
    Kim, Yang Soo
    Lee, Soon Nam
    Ko, Yoon Ho
    Kim, Hwa Jung
    Kang, Jin-Hyoung
    ONCOLOGIST, 2015, 20 (12): : 1440 - 1447
  • [7] Palonosetron (PALO) plus aprepitant (APREP) and dexamethasone (DEX) for the prevention of chemotherapy-induced nausea and vomiting (CINV) after emetogenic chemotherapy (CT)
    Grote, T
    Hajdenberg, J
    Cartmell, A
    Ferguson, S
    Ginkel, A
    Gallagher, S
    Charu, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 794S - 794S
  • [8] Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
    Fujiwara, Satoe
    Terai, Yoshito
    Tsunetoh, Satoshi
    Sasaki, Hiroshi
    Kanemura, Masanori
    Ohmichi, Masahide
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (04) : 311 - 319
  • [9] Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients
    Sento, Shinya
    Kitamura, Naoya
    Yamamoto, Tetsuya
    Nakashiro, Koichi
    Hamakawa, Hiroyuki
    Ibaragi, Soichiro
    Sasaki, Akira
    Takamaru, Natsumi
    Miyamoto, Yoji
    Kodani, Isamu
    Ryoke, Kazuo
    Mishima, Katsuaki
    Ueyama, Yoshiya
    ANTICANCER RESEARCH, 2017, 37 (12) : 6977 - 6981
  • [10] THE EFFICACY OF TRIPLET ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: PALONOSETRON (PALO), APREPITANT (APR), AND DEXAMETHASONE (DEX)
    Yoshizawa, H.
    Sato, K.
    Makino, M.
    Kobayashi, O.
    Tanaka, H.
    Miura, S.
    Watanabe, S.
    Tanaka, J.
    Kagamu, H.
    Ichiei, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 509 - 509
12345